RSS Feeds
Search

Press releases

Press releases

Displaying 11..20 of 22 - per page Previous page Next page
Order by
You are cordially invited to Lawson's Research Day on Wednesday, March 26, 2008 at the London Convention Centre. More
Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx® BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain More
Lawson Health Research Institute has released their 2009 overview brochure, "Discovery: Thinking Ahead" More
STOWIC's IP and processes have been acquired by United Pharmaceuticals of Jordan. More
Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx® GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients More
HEALTHPOINT enters into an agreement with Collegium Pharmaceutical, Inc. to license and sell two of Collegium's late-stage patent-pending topical analgesics, one an over the counter product and the other a prescription application. More
Microarray Analysis Conference: Integrating microarray data analysis approaches into research applications will ensure more efficient drug discovery. More
Translational research has emerged as a key area of clinical R&D in Canadian hospitals and universities, where a focus on integrating drug discovery and development has become a priority. More
Study helps doctors give better care to patients More
Displaying 11..20 of 22 - per page Previous page Next page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us